N Nakashima Selected Research

N Nakashima Research Topics

Disease

5	Neoplasms (Cancer) 10/2004 - 04/2000
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2006 - 05/2000
2	Insulin Resistance 05/2001 - 06/2000
2	Carcinoma (Carcinomatosis) 05/2000 - 01/2000
1	Memory Disorders (Memory Loss) 10/2015
1	Adenocarcinoma 04/2006
1	Inflammation (Inflammations) 03/2004
1	Necrosis 03/2004
1	Emphysema 03/2004
1	Pulmonary Emphysema 03/2004
1	Pulmonary Hypertension 03/2004
1	Aplastic Anemia (Anemia, Hypoplastic) 03/2003
1	Idiopathic Interstitial Pneumonias 02/2003
1	Idiopathic Pulmonary Fibrosis 02/2003
1	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2003
1	Asthma (Bronchial Asthma) 09/2001
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 05/2001
1	Endodermal Sinus Tumor (Endodermal Sinus Tumors) 05/2001
1	Paralysis (Palsy) 02/2001
1	Plasmacytoma 01/2001
1	Amyloid Plaque 01/2001
1	Multiple Myeloma 08/2000
1	Vascular Remodeling 06/2000
1	Genetic Predisposition to Disease (Genetic Predisposition) 06/2000
1	Myocardial Infarction 06/2000
1	Atherosclerosis 06/2000
1	Sleep Apnea Syndromes (Sleep Apnea) 05/2000
1	Synovial Sarcoma (Synovioma) 05/2000
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2000
1	Uterine Cervical Dysplasia 05/2000
1	Apnea 05/2000
1	Disease Progression 05/2000
1	Malaria 03/2000
1	Residual Neoplasm 01/2000
1	Endometrial Neoplasms (Endometrial Cancer) 01/2000
1	Choriocarcinoma 01/2000
1	Ovarian Epithelial Carcinoma 01/2000
1	Familial Hypertrophic Cardiomyopathy (Cardiomyopathy, Familial Hypertrophic) 01/2000
1	Ovarian Neoplasms (Ovarian Cancer) 01/2000
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2000
1	Endometrioid Carcinoma 01/2000

Drug/Important Bio-Agent (IBA)

3	Cisplatin (Platino)FDA LinkGeneric 05/2001 - 01/2000
2	Proteins (Proteins, Gene)FDA Link 06/2000 - 04/2000
2	Insulin (Novolin)FDA Link 06/2000 - 04/2000
2	Glutamyl Aminopeptidase (Aspartyl Aminopeptidase)IBA 05/2000 - 01/2000
1	Betaine (C.B.B.)FDA Link 10/2015
1	Indicators and Reagents (Reagents)IBA 04/2006
1	Messenger RNA (mRNA)IBA 04/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2004
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2004
1	Pancreatic Elastase (Elastase)IBA 03/2004
1	perforin-granzyme BIBA 03/2003
1	T-Cell Intracellular Antigen-1IBA 03/2003
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 02/2003
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2003
1	Metalloproteases (Metalloproteinases)IBA 09/2001
1	Tissue Inhibitor of Metalloproteinase-1IBA 09/2001
1	Matrix Metalloproteinases (MMPs)IBA 09/2001
1	Mitogen-Activated Protein KinasesIBA 05/2001
1	DiglyceridesIBA 05/2001
1	Fatty Acids (Saturated Fatty Acids)IBA 05/2001
1	Protein Kinase CIBA 05/2001
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 05/2001
1	RNA (Ribonucleic Acid)IBA 02/2001
1	Amyloid (Amyloid Fibrils)IBA 01/2001
1	Immunoglobulin kappa-Chains (kappa-Chain, Immunoglobulin)IBA 01/2001
1	Immunoglobulins (Immunoglobulin)IBA 08/2000
1	Immunoglobulin G (IgG)IBA 08/2000
1	Rheumatoid FactorIBA 08/2000
1	Immunoglobulin A (IgA)IBA 08/2000
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 06/2000
1	NucleotidesIBA 06/2000
1	Transforming Growth Factor beta (TGF-beta)IBA 06/2000
1	Insulin ReceptorIBA 06/2000
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 06/2000
1	Insulin Receptor Substrate ProteinsIBA 06/2000
1	ParaffinIBA 05/2000
1	Oxygen (Dioxygen)IBA 05/2000
1	Formaldehyde (Formol)FDA Link 05/2000
1	Tumor Biomarkers (Tumor Markers)IBA 05/2000
1	SYT-SSX fusion proteinIBA 05/2000
1	Protein Tyrosine PhosphatasesIBA 04/2000
1	TensinsIBA 04/2000
1	InsecticidesIBA 03/2000
1	Troponin T (Troponin T1)IBA 01/2000
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2000
1	Etoposide (VP 16)FDA LinkGeneric 01/2000
1	pirarubicinIBA 01/2000
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 01/2000
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2000
1	Carboplatin (JM8)FDA LinkGeneric 01/2000
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2000

Therapy/Procedure

1	Palliative Care (Palliative Therapy) 10/2004
1	Operative Surgical Procedures 07/2001
1	Drug Therapy (Chemotherapy) 05/2001
1	Intravesical Administration 01/2000
1	Therapeutics 01/2000
1	PP regimen 01/2000
1	Adjuvant Chemotherapy 01/2000